Primary Site >> Biliary tract Cancer
Gene >> ROS1
| 1. | |||||||||||
| Journal: | Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19513-8. | ||||||||||
| Title: | Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target. | ||||||||||
| Author: | Saborowski, Anna|Saborowski, Michael|Davare, Monika A|Druker, Brian J|Klimstra, David S|Lowe, Scott W | ||||||||||
| PMID: | 24154728 | ||||||||||
| 2. | |||||||||||
| Journal: | Hepatology. 2014 Apr;59(4):1427-34. | ||||||||||
| Title: | Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. | ||||||||||
| Author: | Arai, Yasuhito|Totoki, Yasushi|Hosoda, Fumie|Shirota, Tomoki|Hama, Natsuko|Nakamura, Hiromi|Ojima, Hidenori|Furuta, Koh|Shimada, Kazuaki|Okusaka, Takuji|Kosuge, Tomoo|Shibata, Tatsuhiro | ||||||||||
| PMID: | 24122810 | ||||||||||
| 3. | |||||||||||
| Journal: | Hum Pathol. 2014 Aug;45(8):1630-8. | ||||||||||
| Title: | Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma. | ||||||||||
| Author: | Graham, Rondell P|Barr Fritcher, Emily G|Pestova, Ekaterina|Schulz, John|Sitailo, Leonid A|Vasmatzis, George|Murphy, Stephen J|McWilliams, Robert R|Hart, Steven N|Halling, Kevin C|Roberts, Lewis R|Gores, Gregory J|Couch, Fergus J|Zhang, Lizhi|Borad, Mites | ||||||||||
| PMID: | 24837095 | ||||||||||
| 4. | |||||||||||
| Journal: | Int J Mol Med. 2014 Sep;34(3):661-8. | ||||||||||
| Title: | Downregulation of ROS-FIG inhibits cell proliferation, colonyformation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells. | ||||||||||
| Author: | Deng, Gang|Hu, Chenghuan|Zhu, Lei|Huang, Feizhou|Huang, Wei|Xu, Hongbo|Nie, Wanpin | ||||||||||
| PMID: | 24968753 | ||||||||||
| 5. | |||||||||||
| Journal: | Genes Chromosomes Cancer. 2014 Dec;53(12):1033-40. | ||||||||||
| Title: | Screening for the FIG-ROS1 fusion in biliary tract carcinomas by nested PCR. | ||||||||||
| Author: | Peraldo Neia, Caterina|Cavalloni, Giuliana|Balsamo, Antonella|Venesio, Tiziana|Napoli, Francesca|Sassi, Francesco|Martin, Vittoria|Frattini, Milo|Aglietta, Massimo|Leone, Francesco | ||||||||||
| PMID: | 25231053 | ||||||||||
| 6. | |||||||||||
| Journal: | BMC Cancer. 2015 Oct 16;15:721. | ||||||||||
| Title: | Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma. | ||||||||||
| Author: | Lee, Kyung-Hun|Lee, Kyoung-Bun|Kim, Tae-Yong|Han, Sae-Won|Oh, Do-Youn|Im, Seock-Ah|Kim, Tae-You|Yi, Nam-Joon|Lee, Kwang-Woong|Suh, Kyung-Suk|Jang, Ja-June|Bang, Yung-Jue | ||||||||||
| PMID: | 26475437 | ||||||||||
| 7. | |||||||||||
| Journal: | Clin Cancer Res. 2016 Jan 15;22(2):291-300. | ||||||||||
| Title: | Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma. | ||||||||||
| Author: | Moeini, Agrin|Sia, Daniela|Bardeesy, Nabeel|Mazzaferro, Vincenzo|Llovet, Josep M | ||||||||||
| PMID: | 26405193 | ||||||||||
| 8. | |||||||||||
| Journal: | Oncotarget. 2016 Jul 19;7(29):46750-46767. | ||||||||||
| Title: | The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets. | ||||||||||
| Author: | Chong, Dawn Q|Zhu, Andrew X | ||||||||||
| PMID: | 27102149 | ||||||||||
| 9. | |||||||||||
| Journal: | Sci Rep. 2016 May 3;6:25369. | ||||||||||
| Title: | Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer. | ||||||||||
| Author: | Chiang, Nai-Jung|Hsu, Chiun|Chen, Jen-Shi|Tsou, Hsiao-Hui|Shen, Ying-Ying|Chao, Yee|Chen, Ming-Huang|Yeh, Ta-Sen|Shan, Yan-Shen|Huang, Shiu-Feng|Chen, Li-Tzong | ||||||||||
| PMID: | 27136744 | ||||||||||
| 10. | |||||||||||
| Journal: | Cancer Res Treat. 2017 Jan;49(1):185-192. | ||||||||||
| Title: | Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma. | ||||||||||
| Author: | Lim, Sun Min|Yoo, Jeong Eun|Lim, Kiat Hon|Meng Tai, David Wai|Cho, Byoung Chul|Park, Young Nyun | ||||||||||
| PMID: | 27121721 | ||||||||||